Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 29, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Single Cell Methylation

Awarded
75N94025Q00167Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The National Institutes of Health, National Institute of Child Health and Human Development intends to award a non-competitive, sole-source contract to Scale Biosciences, Inc. for single-cell methylation reagents. These reagents are essential for high-quality sample preparation in epigenomic research and are uniquely compatible with NIH sequencing core instruments and workflows. Because Scale Biosciences is the exclusive manufacturer and holds the necessary patents and proprietary rights, the government has determined that no other supplier can provide equivalent functionality or performance. This procurement, identified by solicitation number 75N94025Q00167, is conducted under FAR Part 13 Simplified Acquisition Procedures and is not expected to exceed the simplified acquisition threshold of 250,000 dollars. The intended period of performance runs from August 15, 2025, through August 14, 2026. While the government intends to proceed without full and open competition, interested parties may submit capability statements and proposals to the contracting officer by August 8, 2025.

General Info

Contract Value

$115,835

NAICS

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Award Issued Date

Documents

1

Notice of Intent to Sole Source - Single Cell Methylation (75N94025Q00167)

PDF, Low prioritypresolicitation
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Nichd
Contacts1 person available
OfficeBETHESDA, MD, 20817, USA
Office AddressBETHESDA, MD, 20817, USA
Contacts
FALZONE MICHAEL L

Full Description

Show more
INTRODUCTION THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD), Office of Acquisitions (OA) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to: Scale Biosciences, Inc. 5601 Oberlin Dr., Suite 110 San Diego, CA 92121 NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 541715 with a Size Standard 1,000. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-99-1, July 16, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($250,000). STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title: Single Cell Methylation 2. Background Information: These reagents manufactured by Scale Biosciences have become an essential component in modern epigenomic research, enabling the preparation of high-quality samples for single-cell methylation sequencing. This technology is critical for the advanced genomic analysis required by our ongoing research initiatives. Scale Biosciences reagents are uniquely compatible with the National Institutes of Health (NIH) sequencing core instruments and workflows. After a thorough market review, it has been determined that no other known supplier currently offers reagents that provide equivalent functionality or compatibility for single-cell methylation sequencing at this level of resolution and performance. Moreover, Scale Biosciences is the exclusive manufacturer and distributor of these specific methylation reagents and holds the associated patents and/or patent applications protecting the underlying technology. Due to these proprietary rights, no third-party vendors are authorized or capable of supplying equivalent products. Given the technological specificity, performance requirements, and intellectual property protections, procurement from Scale Biosciences is the only viable option to meet our scientific and operational needs. This purchase therefore qualifies as a sole source acquisition. Period of Performance: August 15, 2025 through August 14, 2026 CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by August 8, 2025 at 9:00 AM Eastern time and must reference solicitation number 75N94025Q00167. Responses may be submitted electronically to Mr. Michael Falzone, Contracting Officer at contact@example.gov. Fax responses will not be accepted. "All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nichd

Same awarding agency

NAICS: 811310
New
Federal
AAALAC International Annual Accreditation Fee
Solicitation # 75N98027Q00032
Solicitation 75N98027Q00032 is a non-competitive requirement for the National Institutes of Health (NIH) to procure AAALAC International annual accreditation services. The primary objective is to ensure the NIH Intramural Research Program (IRP) animal program remains in compliance with NIH Policy Manual Chapter 3040-2, which mandates full accreditation by AAALAC International. The scope of work involves providing accreditation services that advance animal welfare in science and education, expand accreditation opportunities, and integrate the 3Rs of animal research and the Culture of Care. The anticipated period of performance is from January 1, 2027, to December 31, 2027, and the government intends to award a firm fixed-price purchase order. The award will be granted to the responsible offeror deemed most advantageous to the government, with technical capability weighted as significantly more important than price. Offerors must maintain active registration in the System for Award Management (SAM) and submit electronic proposals to the designated contracting personnel. Required documentation includes specific FAR and HHSAR representations and certifications regarding telecommunications, service contract labor standards, and ICT accessibility. Invoicing will be processed through the NIH Invoicing Instructions with IPP. The requirement is categorized under NAICS code 811310 (or 813920 per the solicitation text) with a small business size standard of 23.5 million dollars.
Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance

POSTED

3 days ago

DEADLINE

in 8 days
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS